Picture of Nexgel logo

NXGL Nexgel Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapValue Trap

Annual cashflow statement for Nexgel, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-4.31-4.75-3.16-3.28-2.89
Depreciation
Non-Cash Items2.041.880.1160.1490.374
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.593-0.234-0.421-1.170.468
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-2.75-2.99-3.24-3.87-1.31
Capital Expenditures-0.269-0.096-0.696-0.443-0.068
Purchase of Fixed Assets
Other Investing Cash Flow Items-5.55.15-0.332
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-0.269-5.594.46-0.775-0.068
Financing Cash Flow Items-0.1150-0.241-0.177
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities16.3-3.660.3793.750.63
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash13.3-12.21.6-0.893-0.749